Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Oct;6(10):2995-2996.
doi: 10.1002/hep4.1989. Epub 2022 May 9.

Response to Tinospora cordifolia (giloy)-induced liver injury during the COVID-19 pandemic-Multicenter nationwide study from India

Affiliations
Multicenter Study

Response to Tinospora cordifolia (giloy)-induced liver injury during the COVID-19 pandemic-Multicenter nationwide study from India

Harshad Devarbhavi. Hepatol Commun. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Nothing to report.

Comment on

References

    1. Kulkarni AV, Hanchanale P, Prakash V, Kalal C, Sharma M, Kumar K, et al. Tinospora cordifolia (giloy)‐induced liver injury during the COVID‐19 pandemic—multicenter nationwide study from India. Hepatol Commun. 2022. 10.1002/hep4.1904 - DOI - PMC - PubMed
    1. Nagral A, Adhyaru K, Rudra OS, Gharat A, Bhandare S. Herbal immune booster‐induced liver injury in the COVID‐19 pandemic—a case series. J Clin Exp Hepatol. 2021;11:732–8. - PMC - PubMed
    1. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76. - PubMed
    1. Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671–722. - PubMed
    1. Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol. 2009;15:325–9. - PubMed